Delivery Order SPE2DR25D2104-SPE2DR26F3TML
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,357.65 to AmerisourceBergen Drug Corp for the supply of CIBINQO 100 mg tablets in quantities of 30 units. This firm fixed-price delivery order, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, represents a non-competitive award under an existing contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $13,362.26 to AmerisourceBergen Drug Corp for 30-count bottles of CIBINQO 100 MG tablets, with completion expected by December 11, 2025. This non-set-aside, firm fixed-price delivery order was issued under a competitive procurement process and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,818.27 to AmerisourceBergen Drug Corp for CIBINQO 100 mg tablets (30-count units) on November 14, 2025, with an ultimate completion date of November 17, 2025. This competitive award, which carries no set-aside designation, is structured as a firm fixed price delivery order and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Cibinqo 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $7,742.67 and an ultimate completion date of June 2, 2025. The contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,818.27 to AmerisourceBergen Drug Corp for 30-count bottles of Cibinqo 100 mg tablets, a pharmaceutical product to be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 15, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of pharmaceutical products, including CIBINQO 100 MG TABLET. The contract is a Delivery Order with a Firm Fixed Price of $19,691.42 and an Ultimate Completion Date of March 8, 2024. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key...
- This is a $7,246.38 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CIBINQO 100 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through June 26, 2025. The contract is not set aside and was awarded under an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with...
- This federal contract award, valued at $13,935.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a delivery order for the provision of CIBINQO 100 MG TABLET pharmaceutical products. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,511.02 firm fixed-price delivery order contract covers the supply of CIBINQO 100 MG TABLET UU 30S, a medical product, with a performance period extending through March 7, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award, valued at $14,281.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of CIBINQO 100 MG TABLET UU 30S, with a performance period ending on July 13, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a key vendor for federal healthcare programs, particularly within the military and...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TMLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,332.08 to AmerisourceBergen Drug Corp for the supply of CIBINQO 100 mg tablets (30-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement needs serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 1/12/26 |